CPSF1

Cleavage and polyadenylation specificity factor subunit 1 · Q10570 · CPSF1 on Sugi Atlas →

0 patent compounds predicted against CPSF1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CPSF1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Acelarin First Line Randomised Pancreatic Study PHASE2/PHASE3SUSPENDED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors PHASE1COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Study to Explore Natural Daily Variation and Impact of Stress in HIV Levels nanCOMPLETED
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab nanCOMPLETED
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Efficacy Study of a Food Supplement With Myo-inositol, N-Acetyl-Cystein, Zinc and Vitamins on Sperm DNA Fragmentation nanRECRUITING
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
Identification of Viable Human Embryos Using Three Different Methods nanCOMPLETED
Diagnostic and Prognostic Value of MicroRNA in Breast Cancer Patients nanUNKNOWN
MicroRNAs and Cytokines in Peri-Implantitis Tissue nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CPSF1 binder may also engage these)

ProteinNameSimilarity
Q9EPU4 1.000 Q9EPU4 →
Q10569 1.000 Q10569 →
A0A0R4IC37 0.995 A0A0R4IC37 →
Q99P88 0.990 Q99P88 →
P37199 0.986 P37199 →
NUP155 Nuclear pore complex protein Nup155 0.985 landscape →
Q7XWP1 0.984 Q7XWP1 →
Q6P6Z0 0.983 Q6P6Z0 →
Q96RY7 0.983 Q96RY7 →
Q8CEC0 0.983 Q8CEC0 →
A2CEI4 0.983 A2CEI4 →
B1WC10 0.983 B1WC10 →
E9PY46 0.983 E9PY46 →
Q5SQE2 0.982 Q5SQE2 →
Q91WR3 0.982 Q91WR3 →
Q9ESJ4 0.982 Q9ESJ4 →
Q9ESW0 0.981 Q9ESW0 →
Q921C3 0.981 Q921C3 →
Q8C456 0.981 Q8C456 →
Q6PJI9 0.981 Q6PJI9 →
Q9NZQ3 0.981 Q9NZQ3 →
Q8BMG7 0.981 Q8BMG7 →
A1A4K3 0.981 A1A4K3 →
Q1LVE8 0.981 Q1LVE8 →
Q69ZJ7 0.981 Q69ZJ7 →
A0JN52 0.980 A0JN52 →
Q8C0M0 0.980 Q8C0M0 →
P31266 0.980 P31266 →
Q5R7K6 0.980 Q5R7K6 →
Q5RBI5 0.980 Q5RBI5 →